Skip to content

The effect of salacinol, indigestible dextrin, epigallocatechin gallate, monoglucosylrutin, and phlorotannin on the postprandial fat absorption the suppression - A systematic review.

The effect of salacinol, indigestible dextrin, epigallocatechin gallate, monoglucosylrutin, and phlorotannin on the postprandial fat absorption the suppression - A systematic review. - The effect of salacinol, indigestible dextrin, epigallocatechin gallate, monoglucosylrutin, and phlorotannin on the postprandial fat absorption the suppression - A systematic review.

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000050783
Enrollment
Unknown
Registered
2024-04-30
Start date
2023-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult volunteers who do not have a medical condition. We exclude minors, pregnant and breastfeeding women.

Interventions

None listed

Sponsors

FUJIFILM Corporation
Lead Sponsor
Yakujihou Marketing Jimusho Co., Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A systematic literature search is performed through scientific and clinical trial registries databases. The selection criteria are as follows. P: Healthy adult volunteers not suffering from any diseases. We will exclude minors, pregnant women, and lactating women. I: Intake the foods containing salacinol, indigestible dextrin, epigallocatechin gallate, monoglucosy lrutin, and phlorotannin. C: The control food is a placebo food that does not contain salacinol, indigestible dextrin, epigallocatechin gallate, monoglucosyl rutin, and phlorotannin. O: The primary outcome is the suppressive effect on the postprandial fat absorption

Exclusion criteria

Exclusion criteria: The literature which does not meet the key inclusion criteria will be excluded. Intervention tests without a placebo intake group are excluded.

Design outcomes

Primary

MeasureTime frame
The primary outcome is postprandial triglyceride area under the curve (AUC) and RLP-C area under the curve (AUC).

Countries

Japan

Contacts

Public ContactHitomi Saito

FUJIFILM Corporation Bio Science & Engineering Laboratories

hitomi.saito@fujifilm.com080-2119-4836

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026